Progressive multifocal leukoencephalopathy: Difference between revisions

	Progressive multifocal leukoencephalopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Progressive multifocal leukoencephalopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Progressive multifocal leukoencephalopathy On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Progressive multifocal leukoencephalopathy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Progressive multifocal leukoencephalopathy
CDC on Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in the news
Blogs on Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy
Risk calculators and risk factors for Progressive multifocal leukoencephalopathy

Revision as of 23:46, 7 February 2012

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 35: / Line 35: @@
 '''
 ==References==
 {{reflist|2}}
-* Aksamit, A. J. (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosin arabinoside. J Neurovirol 2001;7:386.
-* Berger, J.R. (2003) Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. ''Journal of Neurovirology'' '''9''' (supplement), 38-41. PMID 12709870
-* Langer-Gould, A., Atlas, S. W., Bollen, A. W., Pelletier, D. (2005) Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab. N Engl J Med 2005;353:375-81.
-* Vendrely, A., Bienvenu, B., Gasnault, J., Thiebault, J.B., Salmon, D. and Gray, F. (2005) Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. ''Acta Neuropathologica'' '''109''', 449-455. PMID 15739098
-* Wyen, C., Hoffmann, C., Schmeisser, N., Wohrmann, A., Qurishi, N., Rockstroh, J., Esser, S., Rieke, A., Ross, B., Lorenzen, T., Schmitz, K., Stenzel, W., Salzberger, B. and Fatkenheuer, G. (2004) Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death. ''Journal of Acquired Immune Deficiency Syndrome'' '''37''', 1263-1268. PMID 15385733
 == See also ==